HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy.

Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages. J Virol (2017) 0.76

An advanced BLT-humanized mouse model for extended HIV-1 cure studies. AIDS (2018) 0.75

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 34.97

Viral dynamics in human immunodeficiency virus type 1 infection. Nature (1995) 28.54

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science (1996) 21.81

Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature (2011) 9.30

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA (2012) 8.94

Humanized mice in translational biomedical research. Nat Rev Immunol (2007) 8.83

Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med (2013) 6.63

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med (2006) 5.36

Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One (2013) 3.53

Immune clearance of highly pathogenic SIV infection. Nature (2013) 3.15

Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc Natl Acad Sci U S A (2001) 2.96

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. AIDS (2008) 2.87

The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc Natl Acad Sci U S A (1992) 2.28

Generation of HIV latency in humanized BLT mice. J Virol (2011) 2.20

Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis (2013) 2.17

An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. PLoS Pathog (2013) 2.16

Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One (2010) 1.88

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy. AIDS (2008) 1.56

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV. PLoS Pathog (2016) 1.48

Macrophages and their relevance in Human Immunodeficiency Virus Type I infection. Retrovirology (2012) 1.41

Targeted cytotoxic therapy kills persisting HIV infected cells during ART. PLoS Pathog (2014) 1.32

Human breast milk and antiretrovirals dramatically reduce oral HIV-1 transmission in BLT humanized mice. PLoS Pathog (2012) 1.30

Antiretroviral therapy in macrophages: implication for HIV eradication. Antivir Chem Chemother (2009) 1.27

Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection. J Reprod Immunol (2011) 1.22

Estimating population distributions when some data are below a limit of detection by using a reverse Kaplan-Meier estimator. Epidemiology (2010) 1.21

The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure. AIDS (2014) 1.17

HIV and cells of macrophage/dendritic lineage and other non-T cell reservoirs: new answers yield new questions. J Leukoc Biol (2003) 1.13

CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells. PLoS Pathog (2014) 1.12

Eradication of HIV from the brain: reasons for pause. AIDS (2011) 1.10

Macrophages sustain HIV replication in vivo independently of T cells. J Clin Invest (2016) 1.04

Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir. J Infect Dis (2015) 1.04

Macrophages and HIV-1: An Unhealthy Constellation. Cell Host Microbe (2016) 1.02

HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model. Retrovirology (2013) 0.93

Nonparametric methods for measurements below detection limit. Stat Med (2009) 0.92

The macrophage: a therapeutic target in HIV-1 infection. Mol Cell Ther (2014) 0.90

Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques. J Virol (2016) 0.90

HIV-1 target cells in the CNS. J Neurovirol (2014) 0.89

Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir. AIDS (2016) 0.87

Statistical methods for assays with limits of detection: Serum bile acid as a differentiator between patients with normal colons, adenomas, and colorectal cancer. J Carcinog (2011) 0.78

Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk. J Virol (2016) 0.78

Dynamic cellular finite-element method for modelling large-scale cell migration and proliferation under the control of mechanical and biochemical cues: a study of re-epithelialization. J R Soc Interface (2017) 0.75